Global X Genomics & Biotechn (GNOM) Technical Analysis
$43.73▲0.81%
Market is closed - opens 7 PM, 27 Oct 2025
Insights
- Global X Genomics & Biotechn is currently in a favorable trading position ( BUY ) according to technical analysis indicators.
- Based on analysis of the Oscillators technical indicator, the current market trend for Global X Genomics & Biotechn stock suggests that it is range bound and no decision can be made based on this information
- Based on analysis of the Moving Averages technical indicator, Global X Genomics & Biotechn stock is in a uptrend ↗️
- Based on analysis of the Pivot Points, the current market trend for Global X Genomics & Biotechn stock suggests that it is a good time to buy
Analysis Summary
Oscillators
Sell
Neutral
Buy
Moving Averages
Sell
Neutral
Buy
Pivots
Sell
Neutral
Buy
Oscillators
Name | Value | Action |
|---|---|---|
Relative Strength Index | 65.25 | Sell |
Stochastic | 71.69, 74.87 | Neutral |
Ultimate Oscillator | 53.32 | Neutral |
Stochastic Relative Strength Index | 29.17, 55.28 | Neutral |
Moving Average Convergence Divergence | 1.49, 1.38 | Buy |
Moving Averages
Simple Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 42.62 | Buy |
20 | 41.43 | Buy |
50 | 38.81 | Buy |
Exponential Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 42.75 | Buy |
20 | 41.59 | Buy |
50 | 39.33 | Buy |
Volume Weighted Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 42.56 | Neutral |
20 | 41.46 | Buy |
50 | 38.97 | Buy |
Double Exponential Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 43.85 | Buy |
20 | 43.56 | Buy |
50 | 42.1 | Buy |
Triple Exponential Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 43.81 | Sell |
20 | 44.05 | Buy |
50 | 43.07 | Buy |
Pivot
Pivot | Value |
|---|---|
Resistance L3 | 45.31 |
Resistance L2 | 44.69 |
Resistance L1 | 43.83 |
Pivot Point | 43.21 |
Support L1 | 42.35 |
Support L2 | 41.73 |
Support L3 | 40.87 |
*Disclaimer: The content present here is for informational purposes only, you should not construe any such information or other material as investment advisory.